In the trial of the trivalent subunit influenza vaccine Grippovac CE-AK observations on children aged 3-6 years were made. The preparation showed insignificant reactogenicity and moderate antigenic potency. The trial established that at the period of the epidemic rise of influenza B morbidity the vaccine showed, according to the data of the clinical diagnosis of influenza, insignificant effectiveness, its index of effectiveness (IE) being 1.08; according to the data of the serological diagnosis of influenza, only the A (H1N1) component of the vaccine was found to have IE equal to 1.58.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
vaccine grippovac
8
diagnosis influenza
8
[basic committee
4
committee trial
4
vaccine
4
trial vaccine
4
grippovac se-azh]
4
se-azh] trial
4
trial trivalent
4
trivalent subunit
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!